ATE335507T1 - Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze - Google Patents
Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katzeInfo
- Publication number
- ATE335507T1 ATE335507T1 AT03773451T AT03773451T ATE335507T1 AT E335507 T1 ATE335507 T1 AT E335507T1 AT 03773451 T AT03773451 T AT 03773451T AT 03773451 T AT03773451 T AT 03773451T AT E335507 T1 ATE335507 T1 AT E335507T1
- Authority
- AT
- Austria
- Prior art keywords
- feline
- virus
- leucose
- oncovirus
- cat
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 241000282324 Felis Species 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 101710172711 Structural protein Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000021601 lentivirus infection Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10244863 | 2002-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE335507T1 true ATE335507T1 (de) | 2006-09-15 |
Family
ID=32038184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03773451T ATE335507T1 (de) | 2002-09-23 | 2003-09-19 | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7915035B2 (https=) |
| EP (1) | EP1553977B1 (https=) |
| JP (1) | JP4411213B2 (https=) |
| AT (1) | ATE335507T1 (https=) |
| AU (1) | AU2003281917A1 (https=) |
| DE (2) | DE50304603D1 (https=) |
| DK (1) | DK1553977T3 (https=) |
| ES (1) | ES2270120T3 (https=) |
| WO (1) | WO2004028562A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0901593D0 (en) * | 2009-01-30 | 2009-03-11 | Touchlight Genetics Ltd | Production of closed linear DNA |
| US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
| GB201013153D0 (en) | 2010-08-04 | 2010-09-22 | Touchlight Genetics Ltd | Primer for production of closed linear DNA |
| SMT201900129T1 (it) * | 2011-07-20 | 2019-05-10 | Centre Nat Rech Scient | Vaccino ricombinante contro il virus della leucemia felina contenente un gene ottimizzato dell'involucro del virus della leucemia felina |
| CA3080430A1 (en) | 2017-11-06 | 2019-06-13 | Intervet International B.V. | Feline calicivirus vaccine |
| JP7731670B2 (ja) * | 2017-11-06 | 2025-09-01 | インターベット インターナショナル ベー． フェー． | ネコ白血病ウイルスワクチン |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU607399B2 (en) * | 1985-09-09 | 1991-03-07 | Cetus Corporation | Infectious recombinant virus vaccine for feline leukemia |
| DE69233158T2 (de) * | 1991-03-07 | 2004-05-13 | Connaught Technology Corp., Greenville | Gentechnologisch hergestellter stamm für impfstoffe |
| FR2751223B1 (fr) * | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
| DE19648625A1 (de) * | 1996-11-13 | 1998-05-14 | Soft Gene Gmbh | Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer |
| US6696291B2 (en) * | 1997-02-07 | 2004-02-24 | Merck & Co., Inc. | Synthetic HIV gag genes |
| US6248582B1 (en) * | 1997-10-08 | 2001-06-19 | Imran Khan | Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| SE9803099D0 (sv) * | 1998-09-13 | 1998-09-13 | Karolinska Innovations Ab | Nucleic acid transfer |
| EP1432805B1 (de) * | 2001-10-02 | 2005-05-18 | Mologen AG | Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose |
-
2003
- 2003-09-19 AU AU2003281917A patent/AU2003281917A1/en not_active Abandoned
- 2003-09-19 EP EP03773451A patent/EP1553977B1/de not_active Expired - Lifetime
- 2003-09-19 ES ES03773451T patent/ES2270120T3/es not_active Expired - Lifetime
- 2003-09-19 JP JP2004538747A patent/JP4411213B2/ja not_active Expired - Fee Related
- 2003-09-19 DE DE50304603T patent/DE50304603D1/de not_active Expired - Lifetime
- 2003-09-19 WO PCT/DE2003/003179 patent/WO2004028562A2/de not_active Ceased
- 2003-09-19 DK DK03773451T patent/DK1553977T3/da active
- 2003-09-19 AT AT03773451T patent/ATE335507T1/de active
- 2003-09-19 DE DE10393824T patent/DE10393824D2/de not_active Expired - Fee Related
- 2003-09-23 US US10/528,748 patent/US7915035B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004028562A3 (de) | 2004-06-03 |
| AU2003281917A8 (en) | 2004-04-19 |
| WO2004028562A2 (de) | 2004-04-08 |
| ES2270120T3 (es) | 2007-04-01 |
| EP1553977B1 (de) | 2006-08-09 |
| DK1553977T3 (da) | 2006-11-27 |
| EP1553977A2 (de) | 2005-07-20 |
| DE10393824D2 (de) | 2005-08-11 |
| JP4411213B2 (ja) | 2010-02-10 |
| DE50304603D1 (de) | 2006-09-21 |
| US7915035B2 (en) | 2011-03-29 |
| JP2006511211A (ja) | 2006-04-06 |
| AU2003281917A1 (en) | 2004-04-19 |
| US20060240034A1 (en) | 2006-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60329983D1 (de) | Wachsestersynthase-dna-sequenz, protein und verwendungen davon | |
| AR032231A1 (es) | Nuevas proteinas insecticidas de bacillus thuringiensis | |
| CY1113421T1 (el) | Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα | |
| EA200700904A1 (ru) | Вакцины против вируса японского энцефалита и вируса западного нила | |
| ATE461710T1 (de) | Nipah-virus-impfstoffe | |
| CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
| NO20055838L (no) | Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav | |
| ATE335507T1 (de) | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze | |
| CY1109244T1 (el) | Νευρολοιμογονο στελεχος του ιου δυτικου νειλου και εφαρμογες αυτου. | |
| ATE294857T1 (de) | Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze | |
| ATE380557T1 (de) | E. coli vakzin zur protektion von geflügel gegen colibazillose | |
| DE60238773D1 (de) | Igf-1 als impfstoffhilfsmittel für katzen, insbesondere gegen feline retroviren | |
| WO2004071462A3 (en) | Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction | |
| PT778894E (pt) | Vacina da peritonite infecciosa felina. | |
| ATE476197T1 (de) | Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon | |
| CY1105629T1 (el) | Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv | |
| ATE473013T1 (de) | Induzierte immunantwort gegen den katzen- immunschwäche-virus | |
| CY1107371T1 (el) | Αυξηση της θυμοσινης στην γενετικη ανοσοποιηση | |
| AU2003240866A1 (en) | Antibodies, peptides and vaccines against hiv-1 virus | |
| PA8619101A1 (es) | Polipeptidos recombinantes para diagnosticar la infeccion con el trypanosoma cruzi | |
| WO2004101607A3 (en) | Comparative ligand mapping from mhc class i positive cells | |
| TW200621800A (en) | Human immunodeficiency virus vaccine | |
| WO2005001096A8 (en) | Vaccines against sars | |
| CY1116907T1 (el) | Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων | |
| CY1108543T1 (el) | Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv |